Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01674179 · ClinicalTrials.gov registry record
Quantitative EEG During PSG in Patients With and Without Fibromyalgia
A clinical trial of Fibromyalgia, sponsored by SouthCoast Medical Group.
- Completed
- Registry status
- 560
- Enrollment target
- 1
- Study location
NCT01674179: Completed study of Fibromyalgia, sponsored by SouthCoast Medical Group.
NCT01674179 is a study of Fibromyalgia that has completed, run by SouthCoast Medical Group. The registered enrollment target is 560 participants, above the 172-participant average among 76 other Fibromyalgia trials with a reported enrollment target (226% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01674179, a study of Fibromyalgia, has completed, sponsored by SouthCoast Medical Group.
- COMPLETED
- Registry status
- 560 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to retrospectively analyze Clinical and Nocturnal Polysomnographic Data (Overnight Sleep Studies) in patients with and without Fibromyalgia. Fibromyalgia is a pain syndrome associated with dysfunctional sleep, fatigue, frequent awakenings, non-refreshing sleep, and alpha frequency intrusions. Quantitative EEG during routine Nocturnal Polysomnography can be used to assess Alpha/Delta sleep. Hypothesis: Alpha intrusions may be an objective marker for Fibromyalgia and may correlate with current clinical American College of Rheumatology Criteria for the diagnosis of Fibromyalgia.
Primary Outcome
Assess the sensitivity and specificity of Delta Event/Alpha Event Ratios in Non-REM sleep in patients with and without Fibromyalgia
Conditions Studied
Study Locations (1)
Georgia
- SouthCoast Medical Group - Savannah
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 560 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-10 |
What the finished NCT01674179 record still lists
NCT01674179 is an observational study that tracks outcomes without assigning an intervention. The registered 560 participants enrollment target is mid-sized for trials with a published cap, above the 172-participant average among 76 other Fibromyalgia trials with a reported enrollment target (226% higher).
The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 0 interventions.
NCT01674179 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT01674179 about?
NCT01674179 is a clinical study titled "Quantitative EEG During PSG in Patients With and Without Fibromyalgia". The purpose of this study is to retrospectively analyze Clinical and Nocturnal Polysomnographic Data (Overnight Sleep Studies) in patients with and without Fibromyalgia. Fibromyalgia is a pain syndrome associated with dysfunctional sleep, fatigue, frequent awakenings, non-refreshing sleep, and alph...
What is the current status of trial NCT01674179?
This trial is currently completed. The enrollment target is 560 participants. The study started on 2010-07. Estimated completion is 2012-10.
What conditions does trial NCT01674179 study?
This clinical trial studies the following conditions: Fibromyalgia.
Who is sponsoring clinical trial NCT01674179?
This trial is sponsored by SouthCoast Medical Group, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01674179 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fibromyalgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01674179's enrollment target sits among peer trials
560 5th of 76 higher than 72 of 76 other Fibromyalgia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fibromyalgia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Auricular Neuromodulation in Veterans With Fibromyalgia
RECRUITING · NA
-
Nitrous Oxide as Treatment for Fibromyalgia
RECRUITING · Phase 2
-
The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature
RECRUITING
-
Effects of Breathing and Attention Training (BAT) on Pain Modulation
RECRUITING · NA
-
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04661358 · 560 participants · Phase 3
Fenofibrate for Prevention of DR Worsening
- NCT05473871 · 560 participants · NA
Enhancing Capacity in Churches to Implement PA Programs
- NCT06001541 · 560 participants · NA
Web-based Program to Improve Self-management Among Veterans-caregiver Dyads
- NCT06246916 · 560 participants · Phase 3
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia